e-learning
resources
Munich 2006
Wednesday 06.09.2006
In vivo
and
in vitro
aspects of lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The mechanism of epithelial-mesenchymal transition (EMT) in pulmonary fibrosis
M. Yamada, M. Yoshimi, N. Hamada, T. Maeyama, J. Fukumoto, K. Kuwano, Y. Nakanishi (Fukuoka, Japan)
Source:
Annual Congress 2006 -
In vivo
and
in vitro
aspects of lung injury
Session:
In vivo
and
in vitro
aspects of lung injury
Session type:
Poster Discussion
Number:
4746
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Yamada, M. Yoshimi, N. Hamada, T. Maeyama, J. Fukumoto, K. Kuwano, Y. Nakanishi (Fukuoka, Japan). The mechanism of epithelial-mesenchymal transition (EMT) in pulmonary fibrosis. Eur Respir J 2006; 28: Suppl. 50, 4746
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Respiratory physiology
Related content which might interest you:
TGF-ß participates in epithelial-mesenchymal transition in pleural fibrosis via targeting S100A4
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
TGF-beta-induced transgelin 1 expression contributes to epithelial-to-mesenchymal transition in lung fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 604s
Year: 2006
Arterial remodelling in patients with idiopathic pulmonary fibrosis (IPF) and the possible role of endothelial to mesenchymal transition (EndMT)
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Effect of CCL18 on epithelial-mesenchymal transition (EMT) of alveolar epithelial cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Salvianolate can attenuate bleomycin-induced pulmonary epithelial-mesenchymal transition
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
Small airway epithelial-mesenchymal transition induced by endothelial apoptosis
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
The mesenchymal gene, ADAM33, is not expressed during TGFβ-induced epithelial-mesenchymal transition (EMT) in lung epithelial cells
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007
Epithelial-mesenchymal (EMT) and mesenchymal-epithelial transition (MET) of primary human alveolar epithelial cells? Observations in an injury repair-model using time-lapse imaging
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010
Bronchial epithelial mesenchymal transition (EMT) results is in up-regulation of endothelin-1
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/remodelling in emphysema
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009
Paraquat-induced epithelial-mesenchymal transition: Role of Rac1b/Akt/Twist
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Late Breaking Abstract - Calpain regulates epithelial-mesenchymal transition and its correlation with Akt signaling in pulmonary fibrosis.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
TGFβ-induced epithelial to mesenchymal transition (EMT) as a model of COPD
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
The role of integrins in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 157-162
Year: 2008
Cyclic AMP compartments drive airway epithelial-to-mesenchymal transition (EMT)
Source: International Congress 2018 – Basic pharmacology
Year: 2018
PP121 – Gaq/11 and Ga12/13 promote pulmonary fibrosis by driving distinct myofibroblast functions
Source: ERS Lung Science Conference 2021
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept